Jump to Navigation
Deciphera

Secondary Menu

  • Home
  • Partners
  • News
  • Contact

Home

Deciphera Pharmaceuticals

is dedicated to the design, development and commercialization of unique kinase-inhibiting drugs for the treatment of cancers and immunological diseases. Learn More

Pipeline

News

All News

  • 04.02.2013
    Deciphera announces the promotion of Bryan Smith, Ph.D. to Director of Biology
    Read More
  • 10.04.2012
    Deciphera Pharmaceuticals Announces Transition to an Oncology Drug Development Company
    Read More
  • 08.29.2012
    Deciphera Pharmaceuticals Announces Approval of rebastinib patent in Japan
    Read More
  • 06.11.2012
    Deciphera Pharmacueticals Announces Appointment of Kapil Bhalla, MD to its Scientific Advisory Board
    Read More

Main menu

  • About Us
  • Technology
  • Pipeline
  • Clinical Trials

© 2013 Deciphera Pharmaceuticals, LLC. All Rights Reserved. Site by BOLD.